The Centers for Disease Control and Prevention said people who are merely overweight, not just the obese, may be at high risk of a serious case of COVID-19
Lets get anecdotes! He follows this up with, I think this could be big and, I did my research
As your body adjusts to the medication, the side effects often decrease or disappear
A smaller group describes transient increases
If you are pregnant or planning pregnancy, inform your doctor before receiving this medicine
Phase 2 Clinical Trial Data The landmark Phase 2 trial of retatrutide in obesity was a 48-week, randomized, double-blind, placebo-controlled study published in The New England Journal of Medicine in 2023